Skip to main content
Clinical Trials/ITMCTR2100005235
ITMCTR2100005235
Not yet recruiting
Phase 1

Clinical research on the treatment of degenerative lumbar spondylolisthesis by ''two acupuncture and one moxibustion'' integrated therapy combined with core muscle group training

The First Affiliated Hospital of He'nan University of Chinese Medicine0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
The First Affiliated Hospital of He'nan University of Chinese Medicine
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
The First Affiliated Hospital of He'nan University of Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\. Meet the DLS diagnostic criteria of 1° degenerative lumbar spondylolisthesis (posterior spondylolisthesis);
  • 2\. Enrollment age is greater than 50 years old and less than 75 years old;
  • 3\. The course of the disease is less than 2 years;
  • 4\. Those who have not taken psychotropic drugs before joining the group;
  • 5\. Subjects who have not received Chinese and Western medicines for the treatment of degenerative lumbar spondylolisthesis 2 months before enrollment;
  • 6\. There are no pathological features that affect the results of this subject, such as history of severe lumbar spine trauma, tuberculosis, tumors, fractures, moderate to severe osteoporosis and other lumbar spine bone destruction;
  • 7\. Those who voluntarily participate in this research, sign the informed consent form, and cooperate with the subjects of this subject.

Exclusion Criteria

  • 1\. Low back pain accompanied by severe sensory and motor abnormalities of both lower extremities, spinal cord compression or obvious symptoms of nerve root injury;
  • 2\. Those with severe blood disease, hypertension, diabetes and endocrine system diseases;
  • 3\. Patients with mental disorders or patients who cannot cooperate with the test;
  • 4\. Combination medication or participating in other trials during treatment.

Outcomes

Primary Outcomes

Not specified

Similar Trials